Prahl P
Pediatric Department, University Hospital Gentofte, Copenhagen, Denmark.
Clin Exp Allergy. 1991 Jan;21(1):145-6. doi: 10.1111/j.1365-2222.1991.tb00817.x.
The study was carried out to compare the adrenocortical suppression caused by inhaled beclomethasone dipropionate (BDP) with the suppression caused by budesonide (Bu). The study was of an open cross-over design. Sixteen children with asthma were treated with high-dose inhaled BDP and Bu via a 750 ml spacer (Nebuhaler). Each drug was used for periods of 6 weeks. The 24-hr urinary cortisol excretion was unchanged in 11 subjects. A reproducible suppression of the urinary cortisol excretion was shown in three subjects following BDP and in two subjects following treatment with Bu. The results of the study indicate the occurrence of interpersonal variations of the sensitivity to the adrenocortical suppressive effect of BDP and Bu.
开展该研究以比较吸入丙酸倍氯米松(BDP)和布地奈德(Bu)所引起的肾上腺皮质抑制作用。该研究采用开放交叉设计。16名哮喘儿童通过一个750毫升的储雾罐(Nebuhaler)接受高剂量吸入BDP和Bu治疗。每种药物使用6周。11名受试者的24小时尿皮质醇排泄量未发生变化。3名受试者在使用BDP后以及2名受试者在使用Bu治疗后出现了可重复的尿皮质醇排泄抑制。该研究结果表明,对BDP和Bu的肾上腺皮质抑制作用的敏感性存在个体差异。